178 related articles for article (PubMed ID: 9815559)
1. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
[TBL] [Abstract][Full Text] [Related]
2. Role of (+-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy.
Alderton P; Gross J; Green MD
Cancer Res; 1990 Aug; 50(16):5136-42. PubMed ID: 2116226
[TBL] [Abstract][Full Text] [Related]
3. Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicin.
Giuliani F; Casazza AM; Di Marco A; Savi G
Cancer Treat Rep; 1981; 65(3-4):267-76. PubMed ID: 6263470
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor activities of ME 2303 on human gastrointestinal cancer xenografted to nude mice].
Fujita F; Fujita M; Taguchi T
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1143-50. PubMed ID: 2350190
[TBL] [Abstract][Full Text] [Related]
5. Toxicity of 3'-deamino-3'-(3-cyano-4-morpholinyl) doxorubicin and doxorubicin in nude mice bearing human tumour xenografts.
Ford CH; Richardson VJ; Pushpanathan C; Ali SK
Anticancer Res; 1991; 11(5):1855-62. PubMed ID: 1768056
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effect of pirarubicin (THP) against human colon cancer transplanted into nude mice and the mechanism of cell cycle progression].
Kataoka K; Naomoto Y; Muro M; Kojima K; Horiki S; Hizuta A; Tanaka N; Orita K
Gan To Kagaku Ryoho; 1992 Mar; 19(3):367-71. PubMed ID: 1543363
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of gamma-interferon in ascitic and solid tumor models of human ovarian cancer.
Malik ST; Knowles RG; East N; Lando D; Stamp G; Balkwill FR
Cancer Res; 1991 Dec; 51(24):6643-9. PubMed ID: 1742738
[TBL] [Abstract][Full Text] [Related]
8. Influence of vitamin E and ICRF-187 on chronic doxorubicin cardiotoxicity in miniature swine.
Herman EH; Ferrans VJ
Lab Invest; 1983 Jul; 49(1):69-77. PubMed ID: 6408310
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect and cardiotoxicity of a doxorubicin-lecithin association.
Bellelli A; Giomini M; Giuliani AM; Giustini M; Lorenzon I; Rusconi V; Sezzi ML; Trotta E; Belleli L
Anticancer Res; 1988; 8(1):177-86. PubMed ID: 3358634
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model.
Alderton PM; Gross J; Green MD
Cancer Res; 1992 Jan; 52(1):194-201. PubMed ID: 1727379
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activity of doxorubicin and the bisdioxopiperazine (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the murine sarcoma S180 cell line.
Wadler S; Green MD; Muggia FM
Cancer Res; 1986 Mar; 46(3):1176-81. PubMed ID: 3080237
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor effect of a new anthracycline derivative, MX2, against human glioma cells].
Kuratsu J; Mihara Y; Kochi M; Takaki S; Ushio Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):399-403. PubMed ID: 2930204
[TBL] [Abstract][Full Text] [Related]
13. Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse.
Bertazzoli C; Bellini O; Magrini U; Tosana MG
Cancer Treat Rep; 1979; 63(11-12):1877-83. PubMed ID: 526920
[TBL] [Abstract][Full Text] [Related]
14. Effects of propolis flavonoids on virus infectivity and replication.
Debiaggi M; Tateo F; Pagani L; Luini M; Romero E
Microbiologica; 1990 Jul; 13(3):207-13. PubMed ID: 2125682
[TBL] [Abstract][Full Text] [Related]
15. Rationale and strategy for prevention of anthracycline cardiotoxicity with the bisdioxopiperazine, ICRF-187.
Green MD
Pathol Biol (Paris); 1987 Jan; 35(1):49-53. PubMed ID: 3550612
[TBL] [Abstract][Full Text] [Related]
16. Ameliorative effects of ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] on the cardiotoxicity induced by doxorubicin or by isoproterenol in the mouse.
Flandina C; Sanguedolce R; Rausa L; D'Alessandro N
Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):259-72. PubMed ID: 2128759
[TBL] [Abstract][Full Text] [Related]
17. Antiaggregatory effects of flavonoids in vivo and their influence on lipoxygenase and cyclooxygenase in vitro.
Swies J; Robak J; Dabrowski L; Duniec Z; Michalska Z; Gryglewski RJ
Pol J Pharmacol Pharm; 1984; 36(5):455-63. PubMed ID: 6442773
[TBL] [Abstract][Full Text] [Related]
18. Effect of pretreatment with ICRF-187 on the total cumulative dose of doxorubicin tolerated by beagle dogs.
Herman EH; Ferrans VJ; Young RS; Hamlin RL
Cancer Res; 1988 Dec; 48(23):6918-25. PubMed ID: 3141049
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with ICRF-187 allows a marked increase in the total cumulative dose of doxorubicin tolerated by beagle dogs.
Herman EH; Ferrans VJ; Young RS; Hamlin RL
Drugs Exp Clin Res; 1988; 14(9):563-70. PubMed ID: 3147886
[TBL] [Abstract][Full Text] [Related]
20. [Preclinical evaluation of a new anthracycline derivative, SM-5887 by subrenal capsule assay].
Inoue K; Wang Y; Shibata H; Mukaiyama T; Hamada K; Ogawa M
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3139-42. PubMed ID: 3190252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
